Parathyroid carcinoma (PC) is a rare neuroendocrine neoplasm characterized by excessive production of parathyroid hormone (PTH). Several reports demonstrated only a partial capability of PTH-targeted vaccination to control tumor progression in PC patients actualizing development of new strategies in PC treatment. The goal of this study was to develop adeno-associated viral (AAV) vector vaccines encoding mouse PTH (mPTH) in the native secreted form (AAV-mPTH) or in a glycosylphosphatidylinositol (GPI) anchored form (AAV-mPTH-GPI), and to investigate the immunogenic potential of both vaccines in laboratory mice.
No takes yet. Share an insight, caveat, or question.
Marina Loguinova (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: